CDEK by Data4ThePeople

Sign in Sign up

← All organizations

Zymenex

For profit

Also known as: Zymenex A/S

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Feb 1, 2015

Acquired by Chiesi on Jan 1, 2013

Timeline

1990s

Jan 1, 1998
Zymenex— Founded

2010s

Jan 1, 2013
Chiesi— Acquired By

Drugs by trial phase (3 distinct, 9 trials)

Phase 3 (1 own, 0 via acquisition)

velmanase alfa

Phase 2 (2 own, 0 via acquisition)

Indications

Studied for

Recent trials (14)

NCT02478840Lead sponsorPhase 3Feb 1, 2015
NCT02478840Study chairPhase 3Feb 1, 2015
NCT01908712Lead sponsorPhase 3Aug 1, 2013
NCT01908725Lead sponsorPhase 3Jun 1, 2013
NCT01681953Study chairPhase 3Aug 1, 2012
NCT01681953Lead sponsorPhase 3Aug 1, 2012
NCT01681940Study chairPhase 2Jan 1, 2012
NCT01681940Lead sponsorPhase 2Jan 1, 2012
NCT01285700Lead sponsorPhase 2Jan 1, 2011
NCT01285700Study chairPhase 2Jan 1, 2011
NCT01268358Lead sponsorPhase 1Oct 1, 2010
NCT01268358Study chairPhase 1Oct 1, 2010
NCT01303146CollaboratorPhase 2Oct 1, 2008
NCT00418795Lead sponsorPhase 2Feb 1, 2003

Details

Founded: Hillerod, DK Jan 1, 1998
Last known activity: Feb 1, 2015